welcomes you to the new, improved website!This paper presents an update on diagnostic and prognostic biomarkers in malignant pleural mesothelioma considering also recent molecular biologic achievements as microRNA and genomic sequencing.
You are here:
Editor’s choice: Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know
Submitted by: Joel Dunning
Source: European Journal of Cardio-Thoracic Surgery
Keywords:
Author(s): Isabelle Opitz, Raphael Bueno, Eric Lim, Harvey Pass, Ugo Pastorino, Mattia Boeri, and Gaetano Rocco on behalf of the ESTS Biology Club
